# A Study of Acetyl Hexapeptide-8 (AH8) in Treatment of Blepharospasm

> **NCT00942851** · PHASE1,PHASE2 · COMPLETED · sponsor: **National Institute of Neurological Disorders and Stroke (NINDS)** · enrollment: 24 (actual)

## Conditions studied

- Focal Dystonia

## Interventions

- **DRUG:** Acetyl-Hexapeptide Topical Treatment
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00942851
- **Lead sponsor:** National Institute of Neurological Disorders and Stroke (NINDS)
- **Sponsor class:** NIH
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-07
- **Primary completion:** 2010-10
- **Final completion:** 2010-10
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2012-09-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00942851

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00942851, "A Study of Acetyl Hexapeptide-8 (AH8) in Treatment of Blepharospasm". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00942851. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*